期刊文献+

超声引导下连续椎旁神经阻滞复合全麻在食管癌根治术中应用观察 被引量:1

下载PDF
导出
摘要 目的观察超声引导下连续椎旁神经阻滞复合全麻对食管癌患者应激反应及炎性因子的影响。方法将2017年6月~2018年5月于我院行食管癌根治术的118例患者作为研究对象,将其应用随机数表法分为两组,均59例。入选者均行全身麻醉,于全麻诱导前观察组实施超声引导下连续椎旁神经阻滞,对照组实施连续硬膜外神经阻滞。观察两组麻醉诱导前、术后48h时应激反应及炎性因子水平。结果术后观察组血糖(6.35±0.70)mmol/L、NE(320.74±42.08)pg/ml、E(156.34±17.53)pg/ml、IL-6(142.31±12.47)pg/ml、TNF-α(1.60±0.21)pg/ml水平低于对照组(7.29±0.84)mmol/L、(485.03±46.95)pg/ml、(209.43±25.41)pg/ml、(173.09±10.26)pg/ml、(2.15±0.24)pg/ml,差异有统计学意义(P <0.05)。结论超声引导下连续椎旁神经阻滞复合全麻用于食管癌根治术中是定位更精准,且安全、可行的。
机构地区 光山县人民医院
出处 《西藏医药》 2019年第1期73-75,共3页 Tibetan Medicine
  • 相关文献

参考文献12

二级参考文献84

  • 1杭燕南.麻醉与监护技术[J].外科研究与新技术,2013,2(1):7-13. 被引量:3
  • 2张伟,杨拔贤,孙晓雄.硬膜外阻滞对复合麻醉患者术中内脏灌注的影响[J].北京医学,2005,27(7):398-401. 被引量:1
  • 3Green D, Bidd H, Rashid H. Multimodat intraoperative mo-nitoring:An observational case series in high risk patient in- dergoing major peripheral vascular surgery. Int J Surg, 2014, 12(3) :231-236.
  • 4Ng JM. Update on anesthetic management for esophagectomy. Curr Opin Anaesthesiol, 2011, 24 (1).. 37-43.
  • 5Chan MT, Cheng/3C, Lee TM, et al. BIS-guided anesthesia decreases postoperative delirium and cognitive decline. J Neu- rosurg Anesthesiol, 2013,25 (1) : 33-42.
  • 6Mannion S, Lee P. Bispectral index, sedation, spinal anes- thesia and mortality: time to put the jigsaw puzzle together? Anesth Analg, 2014,118 (5) : 906-908.
  • 7Hunt LP, 13en-Shlomo Y, Clark EM, et al. 90-day mortality after 409,096 total hip replacements for osteoarthritis, from the National Joint Registry for England and Wales: a retro- spective analysis. Lancet, 2013, 382(9898).. 1097-1104.
  • 8Sessler DI, Ben-Eliyahu S, Mascha EJ, et al. Can regional analgesia reduce the risk of recurrence after breast cancer? Methodology of a muhicenter randomized trial[J]. Contemp Clin Trials, 2008, 29(4): 517-526.DOI: 10.1016/j.cct.2008.01.002.
  • 9Richter A, Cederholm I, Fredrikson M, et al. Effect of long-term thoracic epidural analgesia on refractory angina pectoris: a 10-year experience[J]. J Cardiothorac Vasc Anesth, 2012, 26(5):822-828. DOI: 10.1053/j.jvca.2012.01.047.
  • 10Aktas B, Kasimir-Bauer S, Lehmann N, et al. Validity of bone marker measurements for monitoring response to bisphosphonate therapy with zoledronic acid in metastatic breast cancer[J]. Oncol Rep, 2013, 30(1):441-447. DOI: 10.3892/or.2013.2409.

共引文献183

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部